Assessment of Changes in Body Composition After 3 Months of Dulaglutide Treatment.

Shuqin ChenXuepeng WangYong JinXueqin ChenQifa SongGang WeiLi Li

Published in: Diabetes, metabolic syndrome and obesity : targets and therapy (2024)

These results indicate that dulaglutide intervention does not cause muscle and bone mass loss while inducing weight loss, and % change in BF was independently associated with improved glucose control during dulaglutide therapy. This study offers some positive results to support the clinical application of dulaglutide.

Keyphrases

body composition
bone mineral density
weight loss
resistance training
randomized controlled trial
bariatric surgery
skeletal muscle
roux en y gastric bypass
blood glucose
stem cells
type diabetes
gastric bypass
body mass index
high intensity
insulin resistance
replacement therapy
glycemic control